Propel Bio Management’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$12.2M Hold
2025
Q1
$9.27M Sell
2024
Q4
$9.56M Hold
2024
Q3
$9.86M Buy
2024
Q2
$7.69M Hold
2024
Q1
$8.28M Buy
2023
Q4
$2.34M Buy